Related Experiment Video
Updated: Feb 10, 2026

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
Published on: February 2, 2024
Identification of Etiology-Specific Diarrhea Associated With Linear Growth Faltering in Bangladeshi Infants
Amanda E Schnee1, Rashidul Haque2, Mami Taniuchi1
1Division of Infectious Diseases and International Health, School of Medicine, University of Virginia, Charlottesville, Virginia.
Insights
Childhood diarrhea in low-resource settings impacts growth, but specific pathogens like Cryptosporidium and Campylobacter jejuni/coli cause significant linear growth deficits. Pathogen-specific interventions are crucial for improving child development.
Area of Science:
- Global Health
- Infectious Diseases
- Pediatrics
Background:
- Childhood diarrhea in low-resource settings is linked to impaired linear growth.
- The specific impact of different diarrhea-causing pathogens on child growth requires further investigation.
Purpose of the Study:
- To characterize diarrhea etiology in Dhaka, Bangladesh.
- To examine the association between pathogen-specific diarrhea and linear growth (length-for-age z scores) and systemic inflammation (C-reactive protein).
Main Methods:
- Diarrheal stools from children were analyzed using quantitative polymerase chain reaction to identify enteropathogens.
- Attributable fractions were used to determine pathogen-specific diarrhea burdens.
- Linear regression models assessed the relationship between pathogen-specific diarrhea and LAZ and CRP.
Main Results:
- No association was found between all-cause diarrhea and linear growth at 12 months.
- Diarrhea caused by Cryptosporidium, Campylobacter jejuni/coli, and Shigella/enteroinvasive E. coli were significantly associated with linear growth deficits.
- Campylobacter jejuni/coli and Shigella/enteroinvasive E. coli-attributable diarrhea were linked to elevated C-reactive protein levels.
Conclusions:
- The impact of childhood diarrhea on linear growth is pathogen-specific.
- Targeting specific enteropathogens through interventions is essential for mitigating growth shortfalls and inflammation in children.
Abstract:
Childhood diarrhea in low-resource settings has been variably linked to linear growth shortfalls. However, the association between etiology-specific diarrhea and growth has not been comprehensively evaluated. We tested diarrheal stools collected from the Performance of Rotavirus and Oral Polio Vaccines in Developing Countries study from 2011 to 2013 in Dhaka, Bangladesh, by quantitative polymerase chain reaction for a broad range of enteropathogens to characterize diarrhea etiology and examine the association between etiology-specific diarrhea and linear growth and systemic inflammation. Pathogen-specific burdens of diarrhea were determined using attributable fractions. Linear regression was used to examine associations of pathogen-specific diarrhea with length-for-age z scores (LAZ) and serum C-reactive protein. There was no relationship between all-cause diarrhea and length at 12 months (change in 12-month LAZ per episode, -0.01, 95% confidence interval (CI): -0.06, 0.03). However, Cryptosporidium (change in 12-month LAZ per attributable episode, -0.23, 95% CI: -0.50, 0.03), Campylobacter jejuni/coli (change of -0.16, 95% CI: -0.32, -0.01), and Shigella/enteroinvasive Escherichia coli diarrhea (change of -0.12, 95% CI: -0.26, 0.03) were associated with linear growth deficits. Diarrhea attributable to C. jejuni/coli and Shigella/enteroinvasive E. coli were associated with elevated C-reactive protein. The association between diarrhea and linear growth appears to be pathogen-specific, reinforcing the need for pathogen-specific interventions.
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Linear Equations
Linear Circuits
Linear Momentum
Linearization and Approximation

